| RESEARCH PAPER |
|
| Year : 1996 | Volume
: 28
| Issue : 3 | Page : 181-184 |
Evaluation of clinical efficacy and safety of hydroxyethyl starch
Rani P Usha, MUR Naidu, Rao S Manimala, VSSN Murthy, Kumar T Ramesh, JC Shobha, Kumar T Vijay
Correspondence Address:
Rani P Usha
 Source of Support: None, Conflict of Interest: None  | Check |
Hydroxyethyl starch (HES) 6% has been shown to improve hypovolaemia, with minimum side effects and long duration of action. Thirty patients showing signs of hypovolaemia post-operatively, in the form of tachycardia and hypotension received 500 ml of 6% HES intravenously over 30-60 minutes. Administration of HES, significantly improved hypovolaemia in all the patients. Within 30 minutes after infusion, systolic blood pressure (SBP) increased from 85ñ 6 to 98ñ 8 mm Hg. Heart rate decreased from 124ñ 3 beats per minute (bpm) to 99ñ 6 bpm and central venous pressure (CVP) increased from 1ñ 1 to 3.5k1.2 cm of saline, at one hour post HES administration. This improvement persisted till the end of sixth hour observation period. All patients tolerated HES well without any side effects and hematological or biochemical abnormalities.
[PDF]*
|
